Spoken Alpha
KYNTRA BIO, INC.
KYNTRA BIO, INC is a Healthcare company operating in Biotechnology with a $31.5M market cap.
KYNB missed consensus EPS by 0.5% in Q2 FY2026, reported Aug 12, 2026.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-08-23.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for KYNB.
$ curl https://api.spokenalpha.com/v1/companies/KYNBFAQ
Spoken Alpha indexes KYNB's earnings call transcripts at https://spokenalpha.com/companies/KYNB. Each call links to attributed speakers and parsed analyst Q&A. KYNTRA BIO, INC.'s own investor relations page is at https://investor.kyntrabio.com/.
KYNTRA BIO, INC. (KYNB) held its most recent earnings call on 2026-08-13, covering fiscal Q2 2026.
KYNTRA BIO, INC. (KYNB) operates in the Healthcare sector (Biotechnology industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-12 | $-4.68 | $-3.18 | -47.2% | $-1.5M | — | — | EODHD |
| Q1 FY2026 | 2026-05-10 | $-3.76 | $-3.35 | -12.2% | $3.7M | — | — | EODHD |
| Q4 FY2025 | 2026-03-16 | $-3.51 | $-3.88 | +9.7% | $1.3M | — | — | EODHD |
| Q3 FY2025 | 2025-11-09 | $49.61 | $-4.00 | +100.0% | $1.1M | — | — | EODHD |
| Q2 FY2025 | 2025-08-10 | $-1.88 | $1.00 | -100.0% | $1.3M | — | — | EODHD |
| Q1 FY2025 | 2025-05-11 | $1.25 | $0.50 | +100.0% | $2.7M | — | — | EODHD |
| Q4 FY2024 | 2025-03-16 | $0.18 | $-0.17 | +100.0% | $-123.3M | — | — | EODHD |
| Q3 FY2024 | 2024-11-11 | $0.37 | $-9.50 | +100.0% | $46.3M | — | — | EODHD |
| Q2 FY2024 | 2024-08-05 | $-4.00 | $-6.00 | +33.3% | $998.0K | — | — | EODHD |
| Q1 FY2024 | 2024-05-05 | $-8.25 | $-13.25 | +37.7% | $25.4M | — | — | EODHD |
| Q4 FY2023 | 2024-02-25 | $-0.57 | $-0.44 | -29.5% | $27.1M | — | — | EODHD |
| Q3 FY2023 | 2023-11-05 | $-12.98 | $-17.08 | +24.0% | $40.1M | — | — | EODHD |
| Q2 FY2023 | 2023-08-06 | $-22.50 | $-18.00 | -25.0% | $44.3M | — | — | EODHD |
| Q1 FY2023 | 2023-05-07 | $-20.25 | $-18.95 | -6.9% | $36.2M | — | — | EODHD |
| Q4 FY2022 | 2023-02-26 | $-0.70 | $-0.91 | +23.1% | $34.4M | — | — | EODHD |
| Q3 FY2022 | 2022-11-06 | $-24.50 | $-20.62 | -18.8% | $15.7M | — | — | EODHD |
| Q2 FY2022 | 2022-08-07 | $-19.50 | $-21.31 | +8.5% | $29.8M | — | — | EODHD |
| Q1 FY2022 | 2022-05-08 | $-0.68 | $-0.68 | 0.0% | $60.8M | — | — | EODHD |
| Q4 FY2021 | 2022-02-27 | $-36.25 | $-17.50 | -100.0% | $16.5M | — | — | EODHD |
| Q3 FY2021 | 2021-11-08 | $13.50 | $12.08 | +11.8% | $156.0M | — | — | EODHD |
Source: EODHD. KYNB reported actuals as published; sparse fields render as —.